141 related articles for article (PubMed ID: 18223490)
1. A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution.
Toyama T; Hiramatsu N; Yakushijin T; Oze T; Nakanishi F; Yasumaru M; Mochizuki K; Kanto T; Takehara T; Kasahara A; Hayashi N
J Clin Gastroenterol; 2008 Mar; 42(3):317-22. PubMed ID: 18223490
[TBL] [Abstract][Full Text] [Related]
2. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
Omagari K; Honda S; Kadokawa Y; Isomoto H; Takeshima F; Hayashida K; Mizuta Y; Murata I; Kohno S
J Gastroenterol Hepatol; 2004 Jul; 19(7):805-11. PubMed ID: 15209629
[TBL] [Abstract][Full Text] [Related]
3. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.
Hepatology; 1998 Sep; 28(3):751-5. PubMed ID: 9731568
[TBL] [Abstract][Full Text] [Related]
4. A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma.
Kawakita T; Shiraki K; Yamanaka Y; Yamaguchi Y; Saitou Y; Enokimura N; Yamamoto N; Okano H; Sugimoto K; Murata K; Yamakado K; Takeda K; Nakano T
Int J Oncol; 2003 Oct; 23(4):1115-20. PubMed ID: 12963993
[TBL] [Abstract][Full Text] [Related]
5. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
6. Treatment and prognostic factors in patients with hepatocellular carcinoma.
Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
[TBL] [Abstract][Full Text] [Related]
7. Comparison of staging systems to predict survival in hepatocellular carcinoma.
Pascual S; Zapater P; Such J; García-Herola A; Sempere L; Irurzun J; Palazón JM; Carnicer F; Pérez-Mateo M
Liver Int; 2006 Aug; 26(6):673-9. PubMed ID: 16842323
[TBL] [Abstract][Full Text] [Related]
8. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma.
Ramacciato G; Mercantini P; Cautero N; Corigliano N; Di Benedetto F; Quintini C; Ercolani G; Varotti G; Ziparo V; Pinna AD
Ann Surg Oncol; 2005 Apr; 12(4):289-97. PubMed ID: 15827681
[TBL] [Abstract][Full Text] [Related]
9. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
Tateishi R; Yoshida H; Shiina S; Imamura H; Hasegawa K; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Makuuchi M; Omata M
Gut; 2005 Mar; 54(3):419-25. PubMed ID: 15710994
[TBL] [Abstract][Full Text] [Related]
10. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.
Kudo M; Chung H; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
Hepatology; 2004 Dec; 40(6):1396-405. PubMed ID: 15565571
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital].
Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H
Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
13. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
14. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Lin HC; Huang YH; Wu JC; Chiang JH; Lee PC; Lee SD
Cancer; 2006 Jul; 107(1):141-8. PubMed ID: 16708358
[TBL] [Abstract][Full Text] [Related]
15. A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score.
Kitai S; Kudo M; Minami Y; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Takahashi S; Asakuma Y; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
Intervirology; 2008; 51 Suppl 1():86-94. PubMed ID: 18544953
[TBL] [Abstract][Full Text] [Related]
16. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
18. A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.
Yau T; Yao TJ; Chan P; Ng K; Fan ST; Poon RT
Cancer; 2008 Nov; 113(10):2742-51. PubMed ID: 18853421
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis of hepatocellular carcinoma according to new staging classifications].
Caselitz M; Masche N; Flemming P; Stern C; Manns MP; Wagner S; Kubicka S
Dtsch Med Wochenschr; 2004 Aug; 129(33):1725-30. PubMed ID: 15295682
[TBL] [Abstract][Full Text] [Related]
20. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
Huo TI; Lin HC; Hsia CY; Wu JC; Lee PC; Chi CW; Lee SD
Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
